Á lódáil...
Detecting functional changes with [(18)F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy
BACKGROUND: The multitargeting tyrosine kinase inhibitor (TKI) sunitinib is currently the first-line drug therapy for metastasizing renal cell carcinoma (RCC). TKIs have profound effects on tumor angiogenesis, leading to modifications of the tumor microenvironment. The goal of this study was to dete...
Na minha lista:
Foilsithe in: | EJNMMI Res |
---|---|
Main Authors: | , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Springer Berlin Heidelberg
2014
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4451188/ https://ncbi.nlm.nih.gov/pubmed/26116107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-014-0027-5 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|